Sfoglia per AUTORE
SIMIELE M
Collezione ASL Città di Torino

  

Items : 42

2023
ASL Città di Torino

Manca A; Palermiti A; Mula J; Cusato J; Maiese D; Simiele M; De Nicolò A; D'Avolio A;

Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Jul;163:114790. doi: 10.1016/j.biopha.2023.114790. Epub 2023 Apr 29.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

De Nicolò A; De Rosa FG; Di Perri G; Simiele M; Cusato J; Maiese D; Palermiti A; Manca A; Chiara F; Mula J; D'Avolio A;

A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.
2022
ASL Città di Torino

Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;

Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Feb 22;14(2):171. doi: 10.3390/ph14020171.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Brusa P; De Luca A; Collino M; Ravetto Enri L; Torta R; D'Avolio A; Pignata I; Simiele M; Baratta F;

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.
2019
ASL Città di Torino
AOU Città della Salute di Torino

Luzza F; D'Avolio A; Perri GD; Canaparo R; Pellicano R; Riganò D; Simiele M; Agnesod D; Nicolò A; Caviglia GP; Adriani A; Ribaldone DG; Saracco GM; Astegiano M;

Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes. in Frontiers in pharmacology / Front Pharmacol. 2019 Jun 25;10:701. doi: 10.3389/fphar.2019.00701. eCollection 2019.
2019
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Brusa P; Collino M; De Luca A; Pignata I; Ravetto Enri L; Torta R; Baratta F; Simiele M;

Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; D'Avolio A; Carcieri C; Carcieri C; Tomasello C; Simiele M; De Nicolò A; Avataneo V; Canzoneri L; Cusato J; Di Perri G; D'Avolio A;

2017
ASL Città di Torino

Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;

A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jun 5;125:369-75. doi: 10.1016/j.jpba.2016.04.031. Epub 2016 Apr 20.
2016
ASL Città di Torino

Ariaudo A; Favata F; De Nicolò A; Simiele M; Paglietti L; Boglione L; Cardellino CS; Carcieri C; Di Perri G; D'Avolio A;

Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino

Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A; Cusato J; Tomasello C; Simiele M; Calcagno A; Bonora S; Marinaro L; Leggieri A; Allegra S; Di Perri G; D'Avolio A;

Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:35-40. doi: 10.1016/j.jchromb.2015.0
2015
ASL Città di Torino
AOU Città della Salute di Torino

Ranieri VM; D'Avolio A; Di Perri G; Rinaldi M; Ivaldi F; Pasero D; Pensi D; Simiele M;

A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino

Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;

UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:127-32. doi: 10.1016/j.jpba.2015.05.016. Epub 2015 May 22.
2015
ASL Città di Torino

De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A;

Class-specific relative genetic contribution for key antiretroviral drugs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3074-9. doi: 10.1093/jac/dkv207. Epub 2015 Jul 28.
2015
ASL Città di Torino

Siccardi M; Olagunju A; Simiele M; D'Avolio A; Calcagno A; Di Perri G; Bonora S; Owen A;

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8.
2014
ASL Città di Torino

Calcagno A; Nozza S; Simiele M; Milia MG; Chiappetta S; D'Avolio A; Ghisetti V; Lazzarin A; Di Perri G; Bonora S;

UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Sep;98:271-8. doi: 10.1016/j.jpba.2014.05.040. Epub 2014 Jun 7.
2014
ASL Città di Torino

De Nicolò A; Agnesod D; Simiele M; Riganò D; Adriani A; Canaparo R; Astegiano M; Rizzetto M; Di Perri G; D'Avolio A;

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Nov;69(11):3061-6. doi: 10.1093/jac/dku234. Epub 2014 Jul 4.
2014
ASL Città di Torino

D'Avolio A; Carcieri C; Cusato J; Simiele M; Calcagno A; Allegra S; Sciandra M; Trentini L; Di Perri G; Bonora S;

Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Mar;90:119-26. doi: 10.1016/j.jpba.2013.11.027. Epub 2013 Dec 1.
2014
ASL Città di Torino

Agnesod D; De Nicolò A; Simiele M; Mohamed Abdi A; Boglione L; Di Perri G; D'Avolio A;

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jun;94:65-70. doi: 10.1016/j.jpba.2014.01.031. Epub 2014 Jan 31.
2014
ASL Città di Torino

Simiele M; Baietto L; Audino A; Sciandra M; Bonora S; Di Perri G; D'Avolio A;

Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino

De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;

Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction. in Pharmacogenomics / Pharmacogenomics. 2014 Jul;15(10):1281-6. doi: 10.2217/pgs.14.92.
2014
ASL Città di Torino

Calcagno A; Baietto L; Pagani N; Simiele M; Audagnotto S; D'Avolio A; De Rosa FG; Di Perri G; Bonora S;

Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jan;88:66-70. doi: 10.1016/j.jpba.2013.08.022. Epub 2013 Aug 28.
2014
ASL Città di Torino

Baietto L; D'Avolio A; Pace S; Simiele M; Marra C; Ariaudo A; Di Perri G; De Rosa FG;

How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring? in Bioanalysis / Bioanalysis. 2014 Feb;6(4):425-7. doi: 10.4155/bio.13.345.
2014
ASL Città di Torino

Baietto L; Simiele M; D'Avolio A;

Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:42-7. doi: 10.1016/j.jchromb.2013.08.0
2013
ASL Città di Torino

Baietto L; D'Avolio A; Ariaudo A; Corcione S; Simiele M; Cusato J; Urbino R; Di Perri G; Ranieri VM; De Rosa FG;

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2013 May 5;78-79:217-23. doi: 10.1016/j.jpba.2013.02.025. Epub 2013 Feb 27.
2013
ASL Città di Torino

D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G;

Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasma. in Therapeutic drug monitoring / Ther Drug Monit. 2013 Dec;35(6):853-8. doi: 10.1097/FTD.0b013e31829403b1.
2013
ASL Città di Torino

D'Avolio A; Peila E; Simiele M; Pensi D; Baietto L; Cusato J; Cinnirella G; De Rosa F; Di Perri G;

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. in Journal of viral hepatitis / J Viral Hepat. 2013 Apr;20(4):e11-9. doi: 10.1111/jvh.12018. Epub 2013 Feb 18.
2013
ASL Città di Torino

Boglione L; D'Avolio A; Cariti G; Milia MG; Simiele M; De Nicolò A; Ghisetti V; Di Perri G;

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):907-10. doi: 10.1093/jac/dks484. Epub 2012 Dec 5.
2013
ASL Città di Torino

D'Avolio A; Simiele M; Calcagno A; Siccardi M; Larovere G; Agati S; Baietto L; Cusato J; Tettoni M; Sciandra M; Trentini L; Di Perri G; Bonora S;

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2012 Nov;67(11):2645-9. doi: 10.1093/jac/dks285. Epub 2012 Aug 7.
2012
ASL Città di Torino

Baietto L; D'Avolio A; Marra C; Simiele M; Cusato J; Pace S; Ariaudo A; De Rosa FG; Di Perri G;

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino

D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Feb 5;59:109-16. doi: 10.1016/j.jpba.2011.10.003. Epub 2011 Oct 14.
2012
ASL Città di Torino

D'Avolio A; Simiele M; De Francia S; Ariaudo A; Baietto L; Cusato J; Fava C; Saglio G; Di Carlo F; Di Perri G;

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a.
2012
ASL Città di Torino

D'Avolio A; Ciancio A; Siccardi M; Smedile A; Simiele M; Cusato J; Baietto L; Aguilar Marucco D; Cariti G; Calcagno A; Gonzalez de Requena D; Sciandra M; Troshina G; Caviglia GP; Bonora S; Rizzetto M; Di Perri G;

2012
ASL Città di Torino

D?Avolio A; Ciancio A; Siccardi M; Smedile A; Baietto L; Simiele M; Marucco DA; Cariti G; Calcagno A; de Requena DG; Sciandra M; Cusato J; Troshina G; Bonora S; Rizzetto M; Di Perri G;

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2011 Mar 25;54(4):779-88. doi: 10.1016/j.jpba.2010.10.011. Epub 2010 Nov 10.
2011
ASL Città di Torino

D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G;

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2011 Jun;55(6):2976-8. doi: 10.1128/AAC.01236-10. Epub 2011 Mar 14.
2011
ASL Città di Torino

Simiele M; D'Avolio A; Baietto L; Siccardi M; Sciandra M; Agati S; Cusato J; Bonora S; Di Perri G;

2011
ASL Città di Torino

Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G;

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2010 Sep 5;52(5):774-80. doi: 10.1016/j.jpba.2010.02.026. Epub 2010 Feb 25.
2010
ASL Città di Torino

D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Bonora S; Di Perri G;

Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. in Analytical and bioanalytical chemistry / Anal Bioanal Chem. 2010 Jan;396(2):791-8. doi: 10.1007/s00216-009-3263-1. Epub 2009 Nov 9.
2010
ASL Città di Torino

Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Michelazzo M; Ventimiglia G; Siccardi M; Simiele M; Sciandra M; Di Perri G;

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2010 Feb;32(1):86-92. doi: 10.1097/FTD.0b013e3181cacbd0.
2010
ASL Città di Torino

D'Avolio A; Simiele M; Baietto L; Siccardi M; Sciandra M; Patanella S; Bonora S; Di Perri G;

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb.
2010
ASL Città di Torino

Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan WS; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;

2010
ASL Città di Torino

Baietto L; D'Avolio A; Ventimiglia G; De Rosa FG; Siccardi M; Simiele M; Sciandra M; Di Perri G;

2008
ASL Città di Torino

D'Avolio A; Baietto L; Siccardi M; Sciandra M; Simiele M; Oddone V; Bonora S; Di Perri G;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte